Related references
Note: Only part of the references are listed.Targeting p53 for the treatment of cancer
Michael J. Duffy et al.
SEMINARS IN CANCER BIOLOGY (2022)
The purple mangosteen (Garcinia mangostana): Defining the anticancer potential of selected xanthones
Mirielle C. Nauman et al.
PHARMACOLOGICAL RESEARCH (2022)
Expression of TIMPs and MMPs in Ovarian Tumors, Ascites, Ascites-Derived Cells, and Cancer Cell Lines: Characteristic Modulatory Response Before and After Chemotherapy Treatment
Ruth M. Escalona et al.
FRONTIERS IN ONCOLOGY (2022)
The Effect of α-Mangostin and Cisplatin on Ovarian Cancer Cells and the Microenvironment
Paulina Borzdzilowska et al.
BIOMEDICINES (2022)
Adenomatous polyposis coli in cancer and therapeutic implications
Olivia Noe et al.
ONCOLOGY REVIEWS (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Exploring the Intracrine Functions of VEGF-A
Sophie Wiszniak et al.
BIOMOLECULES (2021)
Exosome-mediated transfer of CD44 from high-metastatic ovarian cancer cells promotes migration and invasion of low-metastatic ovarian cancer cells
Xiameng Shen et al.
JOURNAL OF OVARIAN RESEARCH (2021)
CD44: A Multifunctional Mediator of Cancer Progression
Malak Hassn Mesrati et al.
BIOMOLECULES (2021)
Adenomatous Polyposis Coli loss controls cell cycle regulators and response to paclitaxel in MDA-MB-157 metaplastic breast cancer cells
Emily M. Astarita et al.
PLOS ONE (2021)
Clinical relevance of TP53 hotspot mutations in high-grade serous ovarian cancers
Musaffe Tuna et al.
BRITISH JOURNAL OF CANCER (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
BRMS1: a multifunctional signaling molecule in metastasis
Rosalyn C. Zimmermann et al.
CANCER AND METASTASIS REVIEWS (2020)
TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells
Ruth M. Escalona et al.
BMC CANCER (2020)
Cancer-associated fibroblasts induce epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer via CXCL12/CXCR4 axis
Fang Zhang et al.
FUTURE ONCOLOGY (2020)
The role of microenvironment in tumor angiogenesis
Xianjie Jiang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Inhibition of VEGFA Increases the Sensitivity of Ovarian Cancer Cells to Chemotherapy by Suppressing VEGFA-Mediated Autophagy
Xia Li et al.
ONCOTARGETS AND THERAPY (2020)
Epidemiology of ovarian cancer
Patricia Gaona-Luviano et al.
CHINESE CLINICAL ONCOLOGY (2020)
Exosomes: biogenesis, biologic function and clinical potential
Yuan Zhang et al.
CELL AND BIOSCIENCE (2019)
An Integrated Global Analysis of Compartmentalized HRAS Signaling
Tapesh Santra et al.
CELL REPORTS (2019)
Exosome origin determines cell targeting and the transfer of therapeutic nanoparticles towards target cells
Maria Sancho-Albero et al.
JOURNAL OF NANOBIOTECHNOLOGY (2019)
Deregulation of SET is Associated with Tumor Progression and Predicts Adverse Outcome in Patients with Early-Stage Colorectal Cancer
Ion Cristobal et al.
JOURNAL OF CLINICAL MEDICINE (2019)
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients
Renata A. Tassi et al.
BRITISH JOURNAL OF CANCER (2019)
Mechanisms of nuclear content loading to exosomes
Akira Yokoi et al.
SCIENCE ADVANCES (2019)
Comprehensive review on how platinum- and taxane-based chemotherapy of ovarian cancer affects biology of normal cells
Justyna Mikula-Pietrasik et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
I. Ray-Coquard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis
Vu Hong Loan Nguyen et al.
JOURNAL OF OVARIAN RESEARCH (2019)
Correlate the TP53 Mutation and the HRAS Mutation with Immune Signatures in Head and Neck Squamous Cell Cancer
Haoyu Lyu et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2019)
Ovarian cancer-derived extracellular vesicles affect normal human fibroblast behavior
Ilaria Giusti et al.
CANCER BIOLOGY & THERAPY (2018)
Role of CXCL12 and CXCR4 in the pathogenesis of hematological malignancies
Amnon Peled et al.
CYTOKINE (2018)
The role of CXCL12 in tumor microenvironment
Wenfang Meng et al.
GENE (2018)
Crucial biological functions of CCL7 in cancer
Yangyang Liu et al.
PEERJ (2018)
The Role of CXCL12 Axis in Lung Metastasis of Colorectal Cancer
Meng Wang et al.
JOURNAL OF CANCER (2018)
Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicine
Jiang-Jiang Qin et al.
GENES & DISEASES (2018)
Medicinal properties of mangosteen (Garcinia mangostana L.): A comprehensive update
Berenice Ovalle-Magallanes et al.
FOOD AND CHEMICAL TOXICOLOGY (2017)
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
Eric Pujade-Lauraine et al.
LANCET ONCOLOGY (2017)
Role of tumor microenvironment in tumorigenesis
Maonan Wang et al.
JOURNAL OF CANCER (2017)
SET antagonist enhances the chemosensitivity of non-small cell lung cancer cells by reactivating protein phosphatase 2A
Man-Hsin Hung et al.
ONCOTARGET (2016)
Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis
Annette Becker et al.
CANCER CELL (2016)
Tumor microenvironment: The culprit for ovarian cancer metastasis?
Zhongyue Luo et al.
CANCER LETTERS (2016)
Exosomes in tumor microenvironment: novel transporters and biomarkers
Zhen Wang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53
Chinami Makii et al.
ONCOTARGET (2016)
The Role of MDM2 Amplification and Overexpression in Tumorigenesis
Jonathan D. Oliner et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Apoptosis, autophagy, necroptosis, and cancer metastasis
Zhenyi Su et al.
MOLECULAR CANCER (2015)
Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth
Kazuyoshi Shiga et al.
CANCERS (2015)
p53 protein aggregation promotes platinum resistance in ovarian cancer
Y. Yang-Hartwich et al.
ONCOGENE (2015)
Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer
Theresa A. Lawrie et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
FXYD5 is a Marker for Poor Prognosis and a Potential Driver for Metastasis in Ovarian Carcinomas
Pichai Raman et al.
CANCER INFORMATICS (2015)
Ovarian cancer: involvement of the matrix metalloproteinases
Linah Al-Alem et al.
REPRODUCTION (2015)
Expression of IL-18, IL-18 Binding Protein, and IL-18 Receptor by Normal and Cancerous Human Ovarian Tissues: Possible Implication of IL-18 in the Pathogenesis of Ovarian Carcinoma
Liat Medina et al.
MEDIATORS OF INFLAMMATION (2014)
Involvement of SET in the Wnt signaling pathway and the development of human colorectal cancer
Lei Dong et al.
ONCOLOGY LETTERS (2014)
Cell Microenvironment Engineering and Monitoring for Tissue Engineering and Regenerative Medicine: The Recent Advances
Julien Barthes et al.
BIOMED RESEARCH INTERNATIONAL (2014)
The Wnt/β-catenin pathway in ovarian cancer: A review
Rebecca C. Arend et al.
GYNECOLOGIC ONCOLOGY (2013)
VEGFA and tumour angiogenesis
L. Claesson-Welsh et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Role of the recently identified dysadherin in E-cadherin adhesion molecule downregulation in head and neck cancer
Alexandros Georgolios et al.
MEDICAL ONCOLOGY (2012)
MicroRNAs Reprogram Normal Fibroblasts into Cancer-Associated Fibroblasts in Ovarian Cancer
Anirban K. Mitra et al.
CANCER DISCOVERY (2012)
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
Chrisostomi Gialeli et al.
FEBS JOURNAL (2011)
Effects of α-mangostin on apoptosis induction of human colon cancer
Ramida Watanapokasin et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Ovarian Cancer Development and Metastasis
Ernst Langyel
AMERICAN JOURNAL OF PATHOLOGY (2010)
The α-mangostin prevention on cisplatin-induced apoptotic death in LLC-PK1 cells is associated to an inhibition of ROS production and p53 induction
Yesennia Sanchez-Perez et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2010)
Clinical utility of circulating matrix metalloproteinase-7 (MMP-7), CC chemokine ligand 18 (CCL18) and CC chemokine ligand 11 (CCL11) as markers for diagnosis of epithelial ovarian cancer
Samir F. Zohny et al.
MEDICAL ONCOLOGY (2010)
Renoprotection by alpha-mangostin is related to the attenuation in renal oxidative/nitrosative stress induced by cisplatin nephrotoxicity
Jazmin M. Perez-Rojas et al.
FREE RADICAL RESEARCH (2009)
Ovarian cancer: pathology, biology, and disease models
Daniel G. Rosen et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer
Brandon J. Metge et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Metalloproteinases and atherothrombosis: MMP-10 mediates vascular remodeling promoted by inflammatory stimuli
Jose A. Rodriguez et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Interaction between Tumor Suppressor Adenomatous Polyposis Coli and Topoisomerase IIα: Implication for the G2/M Transition
Yang Wang et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
A ROLE FOR IL-18 IN HUMAN NEUTROPHIL APOPTOSIS
Jun-ichi Hirata et al.
SHOCK (2008)
The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2
William G. Stetler-Stevenson
CANCER AND METASTASIS REVIEWS (2008)
Dysadherin: A new, player in cancer progression
Jeong-Seok Nam et al.
CANCER LETTERS (2007)
Characterized mechanism of α-mangostin-induced cell death:: Caspase-independent apoptosis with release of endonuclease-G from mitochondria and increased miR-143 expression in human colorectal cancer DLD-1 cells
Yoshihito Nakagawa et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Tumor microenvironment: The role of the tumor stroma in cancer
Hanchen Li et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1
S Zhang et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
Role of interleukin-18 and its receptor in hepatocellular carcinoma associated with hepatitis C virus infection
M Asakawa et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
p53 and mdm2 as prognostic indicators in patients with epithelial ovarian cancer:: A multivariate analysis
E Dogan et al.
GYNECOLOGIC ONCOLOGY (2005)
A genetically defined model for human ovarian cancer
JS Liu et al.
CANCER RESEARCH (2004)
Cell cycle genes in ovarian cancer: Steps toward earlier diagnosis and novel therapies
G D'Andrilli et al.
CLINICAL CANCER RESEARCH (2004)
Polymorphisms of interleukin (IL)-1α, IL-1β, IL-6, IL-10, and IL-18 and the risk of ovarian cancer
AW Bushley et al.
GYNECOLOGIC ONCOLOGY (2004)
Silencing of H-ras gene expression by retrovirus-mediated siRNA decreases transformation efficiency and tumorgrowth in a model of human ovarian cancer
G Yang et al.
ONCOGENE (2003)
Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis
Y Ino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Share Paper
